Search Results - "Dokoumetzidis, Aristides"

Refine Results
  1. 1

    A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System by Dokoumetzidis, Aristides, Macheras, Panos

    Published in International journal of pharmaceutics (14-09-2006)
    “…Dissolution research started to develop about 100 years ago as a field of physical chemistry and since then important progress has been made. However, explicit…”
    Get full text
    Journal Article
  2. 2

    A Meta-Analysis Methodology in Stan to Estimate Population Pharmacokinetic Parameters from Multiple Aggregate Concentration-Time Datasets: Application to Gevokizumab mPBPK Model by Karakitsios, Evangelos, Dokoumetzidis, Aristides

    Published in Pharmaceutics (01-09-2024)
    “…The aim of the present study was to develop and evaluate the performance of a methodology to estimate the population pharmacokinetic (PK) parameters along with…”
    Get full text
    Journal Article
  3. 3

    On the ubiquitous presence of fractals and fractal concepts in pharmaceutical sciences: A review by Pippa, Natassa, Dokoumetzidis, Aristides, Demetzos, Costas, Macheras, Panos

    Published in International journal of pharmaceutics (18-11-2013)
    “…Fractals have been very successful in quantifying nature's geometrical complexity, and have captured the imagination of scientific community. The development…”
    Get full text
    Journal Article
  4. 4

    Population Pharmacokinetic Modelling of the Complex Release Kinetics of Octreotide LAR: Defining Sub-Populations by Cluster Analysis by Kapralos, Iasonas, Dokoumetzidis, Aristides

    Published in Pharmaceutics (28-09-2021)
    “…The aim of the study is to develop a population pharmacokinetic (PPK) model, of Octreotide long acting repeatable (LAR) formulation in healthy volunteers,…”
    Get full text
    Journal Article
  5. 5

    Donepezil Brain and Blood Pharmacokinetic Modeling after Nasal Film and Oral Solution Administration in Mice by Kaikousidis, Christos, Papakyriakopoulou, Paraskevi, Dokoumetzidis, Aristides, Valsami, Georgia

    Published in Pharmaceutics (05-05-2023)
    “…Intranasal delivery is a non-invasive mode of administration, gaining popularity due to its potential for targeted delivery to the brain. The anatomic…”
    Get full text
    Journal Article
  6. 6

    Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability by Kaikousidis, Christos, Bies, Robert R., Dokoumetzidis, Aristides

    “…We address the problem of model misspecification in population pharmacokinetics (PopPK), by modeling residual unexplained variability (RUV) by machine learning…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Predictive models for oral drug absorption: from in silico methods to integrated dynamical models by Dokoumetzidis, Aristides, Kalantzi, Lida, Fotaki, Nikoletta

    “…Poor oral absorption is one of the most common reasons for a drug to be terminated during development. Oral drug absorption is a complex process affected by…”
    Get more information
    Journal Article
  12. 12

    Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modelling by Karakitsios, Evangelos, Dokoumetzidis, Aristides

    Published in Journal of antimicrobial chemotherapy (03-06-2024)
    “…To develop physiologically based pharmacokinetic (PBPK) models for widely used anti-TB drugs, namely rifampicin, pyrazinamide, isoniazid, ethambutol and…”
    Get full text
    Journal Article
  13. 13

    In Silico Dosimetry Study of Tc99m-Tetrofosmin in Children Using a Novel PBPK Model in Humans Built from SPECT Imaging Data by Kaikousidis, Christos, Dokoumetzidis, Aristides

    Published in Pharmaceutical research (01-02-2023)
    “…Purpose The aim of this work is to develop a Physiologically Based Pharmacokinetic model (PBPK) for the radiopharmaceutical Tc99m-Tetrofosmin in humans, from…”
    Get full text
    Journal Article
  14. 14

    Implementation of non-linear mixed effects models defined by fractional differential equations by Kaikousidis, Christos, Dokoumetzidis, Aristides

    “…Fractional differential equations (FDEs), i.e. differential equations with derivatives of non-integer order, can describe certain experimental datasets more…”
    Get full text
    Journal Article
  15. 15

    Minocycline susceptibility breakpoints for Acinetobacter baumannii: do we need to re-evaluate them? by Tsakris, Athanasios, Koumaki, Vasiliki, Dokoumetzidis, Aristides

    Published in Journal of antimicrobial chemotherapy (01-02-2019)
    “…Abstract Minocycline is an old broad-spectrum tetracycline indicated for the treatment of various infections, including those due to minocycline-susceptible…”
    Get full text
    Journal Article
  16. 16

    Fractional kinetics in drug absorption and disposition processes by Dokoumetzidis, Aristides, Macheras, Panos

    “…We explore the use of fractional order differential equations for the analysis of datasets of various drug processes that present anomalous kinetics, i.e…”
    Get full text
    Journal Article
  17. 17

    Fractional calculus in pharmacokinetics by Sopasakis, Pantelis, Sarimveis, Haralambos, Macheras, Panos, Dokoumetzidis, Aristides

    “…We are witnessing the birth of a new variety of pharmacokinetics where non-integer-order differential equations are employed to study the time course of drugs…”
    Get full text
    Journal Article
  18. 18

    A physiologically based approach for the estimation of recirculatory parameters by Karalis, Vangelis, Dokoumetzidis, Aristides, Macheras, Panos

    “…Indicator dilution studies are used to provide estimates for several physiological parameters such as cardiac output as well as intra- and extravascular…”
    Get more information
    Journal Article
  19. 19

    The Changing Face of the Rate Concept in Biopharmaceutical Sciences: From Classical to Fractal and Finally to Fractional by Dokoumetzidis, Aristides, Macheras, Panos

    Published in Pharmaceutical research (01-05-2011)
    “…The common and most principal component of the underlying mechanism of numerous drug processes is diffusion. The diffusion of molecules at the microscopic…”
    Get full text
    Journal Article
  20. 20